Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D marketing fails to meet CMS guidelines 85% of time

Executive Summary

HHS' Office of Inspector General says that most marketing material for Medicare Part D prescription drug plans fails to meet at least one element of CMS guidelines, ranging from details about PDP benefits and rules to requirements for footnote font size. "It's unconscionable that CMS has let the insurance industry's materials - including essential items like pharmacy directories and summaries of benefits - fail to properly inform seniors 85 percent of the time," Senate Finance Committee Chairman Max Baucus, D-Mont., said. "CMS says it's making changes to correct these problems, and you'd better believe the Finance Committee will move to make sure seniors get better service one way or the other.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050074

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel